Scotts Miracle-Gro reports fiscal 2025 net sales of $3.41 billion

Reuters11-26
Scotts Miracle-Gro reports fiscal 2025 net sales of $3.41 billion

The Scotts Miracle-Gro Company reported net sales of $3,413.1 million for the fiscal year ended September 30, 2025, compared to $3,552.7 million in 2024 and $3,551.3 million in 2023. Cost of sales was $2,348.6 million in 2025, representing 68.8% of net sales, down from 73.7% in 2024 and 76.3% in 2023. The company incurred employee and executive severance charges of $25.3 million in 2025, as well as a non tax-deductible loss on the sale of $17.7 million related to impairment, restructuring, and other items. Net sales remained concentrated in the second and third quarters, accounting for 41.6% and 34.8% of annual net sales in 2025, respectively. The U.S. Consumer segment, Hawthorne segment, and Other segment continued to be the main business divisions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Scotts Miracle-Gro Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000825542-25-000022), on November 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment